SCHEMBL3563897

SCHEMBL3563897

CN(C)CCOc1c[nH]c2ccc(Br)cc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.57
GPR84 Q9NQS5 1/20 0.46
HTR7 P34969 3/20 0.45
TDO2 P48775 1/20 0.44
NR4A2 P43354 1/20 0.43
HTR2A P28223 3/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
CSNK2A1 P68400 1/20 0.41
HTR1B P28222 4/20 0.41
HTR1A P08908 3/20 0.41
HTR1D P28221 3/20 0.41
HTR2C P28335 2/20 0.41
HTR1E P28566 2/20 0.41
HTR2B P41595 2/20 0.41
HTR5A P47898 2/20 0.41
HTR6 P50406 2/20 0.41
ADRA2A P08913 1/20 0.41
DRD2 P14416 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3382239 0.86 SLC6A4 (0.45) SLC6A4GPR84HTR7NR4A2HTR2A
SCHEMBL3558681 0.83 SLC6A4 (0.57) SLC6A4GPR84HTR7NR4A2HTR2A
SCHEMBL3563693 0.82 HTR6 (0.63) SLC6A4GPR84HTR7HTR2ATRPM8
SCHEMBL3555909 0.79 HTR1B (0.55) SLC6A4HTR7HTR2AHTR1BHTR1A
SCHEMBL3554200 0.77 HTR7 (0.45) SLC6A4HTR7TDO2HTR1BADRA2A
SCHEMBL12713875 0.75 IDO1 (0.60) SLC6A4GPR84HTR7NR4A2HTR2A
SCHEMBL29471382 0.75 SLC6A4 (0.83) SLC6A4GPR84HTR7HTR2ATRPM8
SCHEMBL517473 0.75 SLC6A4 (0.83) SLC6A4GPR84HTR7HTR2ATRPM8
SCHEMBL31744724 0.75 GPR84 (0.50) SLC6A4GPR84NR4A2HTR2ATRPM8
SCHEMBL3562128 0.74 SLC6A4 (0.57) SLC6A4GPR84TDO2NR4A2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT SLC6A4 47/4885GPR84 3491/4885HTR7 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.